Showing results (61-70 of 253) with videos related to

Sort By:
Pageof 26
The Lancet. Haematology|November 29, 2023
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approachPeter Dreger, Paolo Corradini, John G Gribben, et al.
Cancer|July 29, 2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantationAnna Dodero, Roberto Crocchiolo, Francesca Patriarca, et al.
Haematologica|March 7, 2007
Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow TransplantationSimona Secondino, Matteo G Carrabba, Paolo Pedrazzoli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2018
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphomaAlessandro Loglio, Mauro Viganò, Glenda Grossi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2012
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantationVittorio Montefusco, Francesco Spina, Francesca Patriarca, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
British Journal of Haematology|October 4, 2024
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real-world study on AIFA monitoring registriesMassimo Breccia, Simone Celant, Francesca Palandri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypesPaolo Corradini, Marco Ladetto, Francesco Zallio, et al.
Haematologica|November 9, 2004
Infliximab treatment for steroid-refractory acute graft-versus-host diseaseFrancesca Patriarca, Alessandra Sperotto, Daniela Damiani, et al.
Investigational New Drugs|February 1, 2021
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphomaMonica Balzarotti, Massimo Magagnoli, Miguel Ángel Canales, et al.
Pageof 26